Publications

Filters

Publications Atlas Journal Article Research Report

Clinical and Practice Brain diseases Cancer and cancer screening Cardiovascular disease Chronic diseases and multimorbidity Diet and nutrition Endocrinology Environmental health Eye, ear, nose and throat disorders Gastroenterology Hematology Infectious diseases Injuries and accidents Internal medicine Kidney disease Lung health Musculoskeletal diseases and disorders Organ transplantation and donation Pharmacoepidemiology and drug safety Reproductive medicine Skin diseases and disorders

Healthcare Providers and Services Acute and emergency services End-of-life care Home and community care Long-term care and continuing care Maternity and neonatal care Mental health and addictions Nursing Pediatrics Pharmacy Primary care Public health Rehabilitation Surgery

People and Society Children and young people Health and healthcare inequality Indigenous Peoples Marginalized populations Older people Racialized communities Women or gender-based research

Research and Methods Data science Decision science Epidemiology Health economics Health services research Implementation science and knowledge translation Policy and program evaluation Statistics Trials

From

ICES Central ICES McMaster ICES North ICES Queen's ICES UofT ICES uOttawa ICES Western

Cancer Cardiovascular Chronic Disease & Pharmacotherapy Kidney, Dialysis & Transplantation Life Stage Mental Health & Addictions Populations & Public Health Primary Care & Health Systems

Showing 1-10 of 25

Journal Article

17/07/2025

Adverse events with co-prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: a population-based retrospective cohort study

Tonial NC, Bota SE, Kang Y, Muanda FT, Urquhart BL, Weir MA. Pharmacotherapy. 2025; Jul 17 [Epub ahead of print].

Journal Article

03/07/2025

Clinical outcomes and health care utilization in patients with advanced chronic kidney disease not on dialysis after the onset of the COVID-19 pandemic in Ontario, Canada

Wang C, Kang Y, Dixon SN, Jeyakumar N, Scott Brimble K, Garg AX, Blake PG, Stukel TA, Oliver MJ, Al-Jaishi A, Clemens KK, Fu L, Ip J, McKenzie S, Moist L, Molnar AO, Muanda-Tsobo F, Reich M, Roshanov P, Silver SA, Wald R, Weir MA, Yau K, Young A, Naylor KL. Can J Kidney Health Dis. 2025; 3;12:20543581251350030.

Journal Article

19/06/2025

Association between statin use and post-ischemic stroke epilepsy among older adults: a nested case-control study

Couper RG, Antaya TC, Carter B, Shariff SZ, Sposato LA, Muanda FT, Burneo JG. Epilepsy Res. 2025; 217:107617. Epub 2025 Jun 19.

Journal Article

08/12/2024

Co-prescription of low-dose methotrexate and trimethoprim-sulfamethoxazole and the 30-day risk of death among older adults: a cohort study

Sadeghi H, Ahmadi F, McArthur E, Sontrop JM, Abdullah SS, Urquhart BL, Kim RB, Muanda FT. Br J Clin Pharmacol. 2024; Dec 8 [Epub ahead of print].

Journal Article

20/10/2024

Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease

Olar P, Garg AX, Weir MA, Ahmadi F, McArthur E, Lam NN, Sontrop JM, Muanda FT. Pharmacol Res Perspect. 2024; 12(6):e70028.

Journal Article

24/06/2024

Thirty-day risk of digoxin toxicity among older adults co-prescribed trimethoprim-sulfamethoxazole versus amoxicillin: a population-based cohort study

Muanda FT, Weir MA, Ahmadi F, McArthur E, Sontrop JM, Abdullah SS, Urquhart BL, Sadeghi H, Kim RB, Garg AX. Pharmacotherapy. 2024; 44(7):558-569. Epub 2024; Jun 24.

Journal Article

23/03/2024

Impact of the 2021 CKD-EPI eGFR equation on kidney care referral criteria in Ontario, Canada: a population-based cross-sectional study

McArthur E, Smith G, Sood MM, Blake PG, Brimble KS, Muanda FT, Garg AX, Dixon SN. Can J Kidney Health Dis. 2024; 11:20543581241229258. Epub 2024 Mar 23.

Journal Article

27/11/2023

Low-dose methotrexate and serious adverse events among older adults with chronic kidney disease

Muanda FT, Blake PG, Weir MA, Ahmadi F, McArthur E, Sontrop JM, Urquhart BL, Kim RB, Garg AX. JAMA Netw Open. 2023; 6(11):e2345132. Epub 2023 Nov 27.

Journal Article

23/06/2023

Adverse events with quetiapine and clarithromycin coprescription: a population-based retrospective cohort study

Yau K, McArthur E, Jeyakumar N, Muanda FT, Kim RB, Clemens KK, Wald R, Garg AX. Health Sci Rep. 2023; 6(6):e1375. Epub 2023 Jun 23.

Journal Article

27/03/2023

Hypocalcemia risk of denosumab across the spectrum of kidney disease: a population-based cohort study

Cowan A, Jeyakumar N, McArthur E, Fleet JL, Kanagalingam T, Karp I, Khan T, Muanda FT, Nash DM, Silver SA, Thain J, Weir MA, Garg AX, Clemens KK. J Bone Miner Res. 2023; 38(5):650-8. Epub 2023 Mar 27.

1 2 3 Next »

Publications

Filters

Resource Type

Topic

Date

ICES Scientists

ICES Site

Research Program

Adverse events with co-prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: a population-based retrospective cohort study

Clinical outcomes and health care utilization in patients with advanced chronic kidney disease not on dialysis after the onset of the COVID-19 pandemic in Ontario, Canada

Association between statin use and post-ischemic stroke epilepsy among older adults: a nested case-control study

Co-prescription of low-dose methotrexate and trimethoprim-sulfamethoxazole and the 30-day risk of death among older adults: a cohort study

Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease

Thirty-day risk of digoxin toxicity among older adults co-prescribed trimethoprim-sulfamethoxazole versus amoxicillin: a population-based cohort study

Impact of the 2021 CKD-EPI eGFR equation on kidney care referral criteria in Ontario, Canada: a population-based cross-sectional study

Low-dose methotrexate and serious adverse events among older adults with chronic kidney disease

Adverse events with quetiapine and clarithromycin coprescription: a population-based retrospective cohort study

Hypocalcemia risk of denosumab across the spectrum of kidney disease: a population-based cohort study